Press Releases

Alfa Chemistry Expands Selection of Click Chemistry Reagents: DBCO, BCN, and Tetrazines Included

Cresset® Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology

Drug discovery specialists Cresset have signed an international collaboration agreement with top global chemical building block providers Enamine to develop new drug discovery technology that can help identify viable drug candidates and unlock future treatment options

Huateng Pharma Introduces Semaglutide Side Chain

Huateng Pharma, a leading provider of high-quality pharmaceutical intermediates, is proud to unveil its latest breakthrough product: Semaglutide Side Chain. This innovative addition to Huateng Pharma's portfolio represents a significant milestone in pharmaceutical innovation, offering a range of compounds including AEEA-AEEA (CAS NO.: 1143516-05-5), SNAC (CAS NO.: 203787-91-1), tBuO-Ste-Glu(AEEA-AEEA)-OtBu (CAS NO.:1118767-16-0), and Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH (CAS NO.: 1662688-20-1).

Rare Disease Day: Emmes Endpoints Solutions Submits Duchenne Video Assessment Qualification Plan to FDA

AES Clean Technology appoints new Vice President of Engineering

Montgomeryville, Pennsylvania, February 20th, 2024: AES Clean Technology, a leading provider of high-performance modular cleanroom facilities, has appointed Chris Barbieri as Vice President of Engineering. With over 20 years of experience in the life science industry and deep expertise in engineering and project delivery, Chris will oversee all aspects of engineering operations, including product development, innovation, and technological advancement initiatives that are aligned with AES’ strategic vision. In addition, he will focus on streamlining the team’s processes, driving consistency, and fostering a culture of technical excellence and innovation.

Biotium Expands Selection of Novel Nuclear Stains for Enhanced Multiplexing Flexibility for Microscopy and Flow Cytometry Applications

Biotium has announced the expansion of its NucSpot® Nuclear Stains lineup, offering unprecedented specificity and flexibility for nuclear counterstaining.

Horizon CME Announces First Annual Summit for Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer)

Horizon CME has announced its sponsorship of the first annual summit for the multidisciplinary conference, Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer).

ENPICOM partners with Erasmus University Medical Center in groundbreaking effort to discover nanobodies against cancer

ENPICOM has announced a collaboration with Erasmus Medical Center. This partnership aims to identify and develop nanobodies against cancer by utilizing ENPICOM’s immune repertoire data analysis services and software solutions.

Novel Drug Delivery System Unveiled: CD Formulation Launches Oral Thin Films Technology

Paradigm Clinical Research Expands Into Boise, Idaho, Advancing the Company’s Portfolio of Therapeutic Area Expertise

CD BioSciences Announces Its Self-Developed Alginate Products, Looking to Fulfill Research Needs

CD BioSciences is pleased to announce the launch of their latest self-developed alginate products, looking to fulfill scientific research demands.

Alfa Chemistry Unveils Expanded Assortment of Derivatization Reagents for Use in Gas Chromatography (GC)

Amerigo Scientific Launches DOPC Nanodiscs as An Invaluable Tool for Handling Membrane Proteins

Clinical Trial Media Tops Over 1,000 Participants Enrolled in Alzheimer’s Disease Studies Across 400 Trial Sites

Clinical Trial Media is Responsible for Identifying, Recruiting and Contributing Over 45% of Participants Across Multiple High-Demand Trials

REMEDI8 Highlights Mobile Containment Unit for Infection Control in the Healthcare Industry

HEPA-10X mitigates the spread of infection in high-risk healthcare environments

Catawba Research Collaborates With Bingli Inc. to Make Patient Pre-Screening Easier for Participants and Sites

PrecisionLife and Metrodora Institute Partner to Accelerate the Diagnosis and Treatment of Long COVID, ME/CFS, and other Chronic Conditions

PrecisionLife and Metrodora Institute are co-investing in a first-of-its-kind partnership to jumpstart the diagnosis and treatment options for a range of complex, chronic diseases including Long COVID, ME/CFS, ALS, Sjögren's syndrome, and many more.

uMed helps Queen Mary University of London and University College London move closer to understanding Parkinson’s risk factors as first-of-its-kind study exceeds 10,000 participant milestone

uMed, the health and research technology company has played a crucial role in expanding the participant base of PREDICT-PD - a joint studybetween Queen Mary University of London and University College London (UCL), and funded by Parkinson’s UK investigating the onset and early stages of Parkinson's disease

Biofourmis Secures Four New Agreements with Top-20 Pharma on Strength of Platform for Digital Clinical Trials and Digital Biomarkers

Biofourmis Secures Four New Agreements with Top-20 Pharma on Strength of Platform for Digital Clinical Trials and Digital Biomarkers

Abzena Launches LabZient™, an Analytical Platform to Expedite the Path to IND for Antibodies

Abzena launches LabZient™, an analytical platform accelerating antibody development timelines by combining predictive in-silico evaluation with laboratory methods. LabZient™ streamlines assessment, reduces costs, and enables early measurement of critical quality attributes. Fit-for-purpose across various antibody types, including mAbs and ADCs, LabZient™ enhances efficiency in biopharma development.